Therapeutic and Prophylactic Vaccines to Counteract Fentanyl Use Disorders and Toxicity.

Journal of Medicinal Chemistry
Christine RobinsonMarco Pravetoni

Abstract

The incidence of fatal overdoses has increased worldwide due to the widespread access to illicit fentanyl and its potent analogues. Vaccines offer a promising strategy to reduce the prevalence of opioid use disorders (OUDs) and to prevent toxicity from accidental and deliberate exposure to fentanyl and its derivatives. This study describes the development and characterization of vaccine formulations consisting of novel fentanyl-based haptens conjugated to carrier proteins. Vaccine efficacy was tested against opioid-induced behavior and toxicity in mice and rats challenged with fentanyl and its analogues. Prophylactic vaccination reduced fentanyl- and sufentanil-induced antinociception, respiratory depression, and bradycardia in mice and rats. Therapeutic vaccination also reduced fentanyl intravenous self-administration in rats. Because of their selectivity, vaccines did not interfere with the pharmacological effects of commonly used anesthetics nor with methadone, naloxone, oxycodone, or heroin. These preclinical data support the translation of vaccines as a viable strategy to counteract fentanyl use disorders and toxicity.

References

Aug 3, 1989·European Journal of Pharmacology·N NishidaM Fujino
Oct 24, 1998·The Journal of Biological Chemistry·K LimD S Linthicum
May 24, 2000·Proceedings of the National Academy of Sciences of the United States of America·M R CarreraK D Janda
Jun 12, 2003·Journal of the American Chemical Society·Michael M MeijlerKim D Janda
Aug 23, 2005·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Jeffrey S MillerAngela Panoskaltsis-Mortari
Aug 23, 2005·Emergency Medicine Journal : EMJ·S F J ClarkeA L Jones
Apr 8, 2009·Pharmacology, Biochemistry, and Behavior·Amira Y Moreno, Kim D Janda
Jan 29, 2010·Molecular Pharmaceutics·Amira Y MorenoKim D Janda
Jun 23, 2011·Journal of Medicinal Chemistry·G Neil StoweKim D Janda
Jun 6, 1997·Environmental Toxicology and Pharmacology·Y AwasakiS Sato
Nov 15, 2011·Journal of Molecular Biology·Kaspars TarsPatrik Maurer
Jan 21, 2012·The Journal of Pharmacology and Experimental Therapeutics·M PravetoniP R Pentel
Sep 25, 2012·Journal of Analytical Toxicology·James R RichesChristopher M Timperley
Feb 13, 2013·Journal of the American Chemical Society·Xiaoqing CaiKim D Janda
May 8, 2013·Proceedings of the National Academy of Sciences of the United States of America·Joel E SchlosburgGeorge F Koob
Jan 28, 2014·Journal of Immunological Methods·J J TaylorM Pravetoni
May 8, 2014·Journal of Chemical Theory and Computation·Callum J DicksonRoss C Walker
May 15, 2015·The Journal of Immunology : Official Journal of the American Association of Immunologists·Megan LaudenbachMarco Pravetoni
Jun 30, 2015·Drug and Alcohol Dependence·M L MillerM A Taffe
Apr 29, 2016·Immunopharmacology and Immunotoxicology·Michael J McCluskieHeather L Davis
Jul 22, 2016·Human Vaccines & Immunotherapeutics·Marco Pravetoni
Dec 30, 2016·MMWR. Morbidity and Mortality Weekly Report·Rose A RuddLawrence Scholl
Jan 10, 2017·Drug and Alcohol Dependence·Joji Suzuki, Saria El-Haddad
Feb 6, 2017·MMWR. Morbidity and Mortality Weekly Report·Anthony J TomassoniGail D'Onofrio
Jun 3, 2017·Journal of the American Chemical Society·Paul T BremerKim D Janda
Sep 19, 2017·Expert Review of Vaccines·R David HeekinThomas R Kosten
Oct 19, 2017·Neuropharmacology·Patil ArmenianKara L Lynch
Jan 11, 2018·Therapeutic Advances in Drug Safety·Rachael Rzasa Lynn, J L Galinkin
Mar 22, 2018·ACS Chemical Neuroscience·Candy S HwangKim D Janda
Mar 30, 2018·MMWR. Morbidity and Mortality Weekly Report·Puja SethSarah Bacon
Apr 24, 2018·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Sue LanghamWilliam C N Dunlop

❮ Previous
Next ❯

Citations

Jul 21, 2021·The Journal of Immunology : Official Journal of the American Association of Immunologists·April M Huseby KelcherMarco Pravetoni
Oct 19, 2021·ACS Pharmacology & Translational Science·Andrew J KassickSaadyah Averick

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bradyarrhythmias

Bradyarrhythmias are slow heart rates. Symptoms may include syncope, dizziness, fatigure, shortness of breath, and chest pains. Find the latest research on bradyarrhythmias here.

Related Papers

Anesthesiology
Edward S Thompson
North Carolina Medical Journal
S L Hicks
Dental Anaesthesia and Sedation
© 2021 Meta ULC. All rights reserved